While we are increasingly able to treat patients more precisely based on their personal disease and metabolic characteristics, we will also have to recognize that these patients are much older. In the United States, the number of people 85 years and older will grow from 5.8 million today to 19 million by 2050.
In contrast, drug product design, development and manufacturing, has not changed much over the past decades and still relies on the one-size-fits-all product concept. Poor adherence, medication errors, inappropriate medication alterations, and medication management issues are increasingly recognized to be responsible for safety issues and poor therapeutic outcomes in special patient populations.
Considering how patients interact with, understand, and use the drug product is a critical prerequisite to conceptualize, design, and develop patient-centered drug products. Patient-centered drug products can fulfill the therapeutic needs of the patient as well as take into consideration the personal patient factors that are important in managing drug therapy. The ultimate goal is to develop drug products that are used intuitively as intended.
Coni-Snap® sprinkle capsules are new generation of patient-centric capsules specifically designed to meet the needs of a rapidly growing number of patients that have difficulty swallowing.
Consumer tests have confirmed that Coni-Snap sprinkle capsules are easier to open than traditional capsules. Including parents, caregivers, and elderly patients, 81% of participants described the design as easy or very easy to open.